NGEN
NERVGEN PHARMA CORP.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 7/2/2026 | View on SEC |
| SUPPL | 7/2/2026 | View on SEC |
| 6-K | 6/1/2026 | View on SEC |
| EFFECT | 5/26/2026 | View on SEC |
| 6-K | 5/26/2026 | View on SEC |
| SUPPL | 5/26/2026 | View on SEC |
| F-X | 5/26/2026 | View on SEC |
| F-10 | 5/26/2026 | View on SEC |
| 6-K | 5/22/2026 | View on SEC |
| SUPPL | 5/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NGEN |
| Company Name | NERVGEN PHARMA CORP. |
| CIK | 1751912 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | 6047225361 |